Negocios · 12/11/20081 min de lectura
Notice of Approval of Original Abbreviated New Animal Drug Application; Phenylbutazone Tablets
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is providing notice that it has approved an original abbreviated new animal drug application (ANADA) filed by First Priority, Inc. The ANADA provides for veterinary prescription use of phenylbutazone tablets in horses for the relief of inflammatory conditions associated with the musculoskeletal system.